Mercator Medical S.A. (WSE:MRC)

Mercator Medical Balance Sheet

Financials in millions PLN. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	138.44	140.9	123.15	217.33	223.34	339.61
Short-Term Investments	32.94	58.76	126.96	109.53	198.46	195.7
Cash & Short-Term Investments	171.38	199.67	250.11	326.86	421.8	535.3
Cash Growth	-13.73%	-20.17%	-23.48%	-22.51%	-21.20%	-2.17%
Accounts Receivable	130.51	75.79	91.86	61.17	49.97	99.27
Other Receivables	32.6	23.35	15.22	42.51	19.54	25.32
Receivables	163.11	99.39	160.18	104.11	69.92	124.6
Inventory	212.12	193.6	214.65	153.09	204.67	253.36
Prepaid Expenses	0.57	0.48	0.49	0.52	0.45	0.56
Other Current Assets	1.11	0.72	0.7	0.66	0.72	0.35
Total Current Assets	548.29	493.84	626.13	585.24	697.56	914.17
Property, Plant & Equipment	345.95	334.28	303.66	251.66	281.96	334.65
Long-Term Investments	20.17	19.87	5.63	2.01	0.73	-
Other Intangible Assets	24.11	27.67	31.75	33.14	24.11	9.65
Long-Term Deferred Tax Assets	25.55	26.96	29.85	24.16	29.7	28.38
Other Long-Term Assets	16.37	28.22	17.91	2.96	4.05	1.68
Total Assets	1,084	1,029	1,036	965.23	1,083	1,289

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	58.43	64.67	77.29	53.49	35.8	62.41
Accrued Expenses	12.38	9.8	10.1	9.61	12.85	16.03
Short-Term Debt	3.29	0.07	0.05	0.15	0.21	-
Current Portion of Leases	6.38	4.82	1.44	0.85	0.72	1.31
Current Income Taxes Payable	0.13	0.75	2.4	4.24	0.03	24.61
Current Unearned Revenue	0.63	0.24	0.2	0.63	3.1	27.72
Other Current Liabilities	30.97	14.89	5.4	9.51	7.25	0.97
Total Current Liabilities	112.22	95.23	96.87	78.47	59.96	133.05
Long-Term Leases	15.29	18.09	3.07	4.41	2.46	3.52
Long-Term Unearned Revenue	-	-	-	0.15	0.16	0.16
Long-Term Deferred Tax Liabilities	9.62	11.11	15.78	20.87	8.54	4.35
Other Long-Term Liabilities	3.8	3.7	2.55	1.61	2.73	2.23
Total Liabilities	140.92	128.12	118.28	105.52	73.85	143.32

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	9.27	9.27	9.77	10.65	10.65	10.65
Additional Paid-In Capital	30.74	30.74	30.74	30.74	57.84	57.84
Retained Earnings	949.18	904.13	887.47	854.82	888.22	1,079
Comprehensive Income & Other	-41.82	-39.92	-7.06	-34.12	52.02	-3.28
Total Common Equity	947.36	904.22	920.92	862.09	1,009	1,144
Minority Interest	-4.19	-3.03	-3.16	-2.38	0.49	1.36
Shareholders' Equity	943.17	901.19	917.76	859.71	1,009	1,145
Total Liabilities & Equity	1,084	1,029	1,036	965.23	1,083	1,289

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	24.96	22.97	4.56	5.41	3.39	4.83
Net Cash (Debt)	146.42	176.7	245.55	321.45	418.41	530.47
Net Cash Growth	-16.26%	-28.04%	-23.61%	-23.17%	-21.12%	-2.29%
Net Cash Per Share	15.99	19.16	26.15	33.54	42.82	52.41
Filing Date Shares Outstanding	9.27	9.27	9.77	9.77	10.65	10.65
Total Common Shares Outstanding	9.27	9.27	9.77	9.42	10.65	10.65
Working Capital	436.07	398.61	529.26	506.76	637.6	781.12
Book Value Per Share	102.21	97.55	94.26	91.54	94.74	107.43
Tangible Book Value	923.25	876.55	889.17	828.95	984.62	1,134
Tangible Book Value Per Share	99.61	94.57	91.01	88.02	92.48	106.53
Land	-	42.4	45.99	41.8	47.24	51.94
Buildings	-	134.64	118.6	100.87	110.96	79.99
Machinery	-	276.87	274.18	223.41	201.74	172.21
Construction In Progress	-	35.88	5.68	1.07	32.75	115.12

Data Source: S&P Global Market Intelligence Last updated: Sep 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 31, 2026

Data Sources Report a data error